Given that a number of studies appear to a support a protective role for the overexpression of specific Rab proteins in various neurodegenerative diseases, such compounds may hold promise in stimulating Rab proteins reportedly inhibited as a consequence of the AD process. This evidence concerns the gene AGFG1 and Alzheimer disease.